Reversing Liver Fibrosis: Dr. Jennifer Chen's NASH Breakthrough

Dr. Jennifer Chen, University of California, San Francisco, Harrington Scholar, is working towards creating a novel therapy for nonalcoholic steatohepatitis (NASH), a chronic inflammation of the liver that can lead to serious damage in the form of scarring (cirrhosis) or liver cancer. Dive into the world of nonalcoholic steatohepatitis (NASH) and discover the potential game-changer, acid ceramidase (aCDase).

Chen explains a future with effective NASH treatments, making a difference in the lives of millions.

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio fulfills its mission to accelerate promising discoveries into medicines for unmet needs. Learn more: https://www.HarringtonDiscovery.org

University Hospitals is one of the nation’s leading health care systems, providing patient-centered care that meets the highest standards for quality and patient safety and have received numerous awards and recognitions from some of the most prestigious institutions in the country for our leadership and exceptional patient outcomes. As an accountable care organization, we foster long-term patient-provider relationships that help promote preventive care, increase wellness and healthy behaviors, decrease emergency episodes, and prevent hospitalizations. To learn more: https://www.uhhospitals.org